ROIV
Roivant Sciences Ltd
35.80$
-0.9%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| -44,071.8% | -1,125.5% | -2,320.4% | -1,225.9% | -2,674.9% | -2,339.3% | -2,889.4% | -9,084.1% | |
| – | 8.8% | 24.9% | 10.7% | 59.8% | 67.4% | 48.4% | 40.5% | |
| 2,532.7% | 181.1% | 357.0% | 1,021.9% | 690.7% | 610.2% | 994.8% | 4,190.9% | |
| -1,342.8% | -2,913.7% | 619.1% | 402.1% | 874.9% | – | – | – | |
| 2,137.4% | 22.6% | 302.3% | 28.4% | 20.1% | 58.2% | -265.2% | -7,527.8% | |
| 490.4% | 7.3% | 24.4% | 31.5% | 40.2% | 4.2% | 15.8% | 99.4% | |
| -2,478.8% | 2,503.8% | -133.2% | 548.6% | -140.4% | 15,906.9% | -6,079.5% | -8,260.7% | |
| – | – | – | – | 516.1% | 18.3% | – | – | |
| -317.3% | -1,755.8% | -0.5% | – | 1.0% | 2.9% | -4,451.3% | -3,868.1% | |
| 7,566.1% | 76.4% | 62.2% | 26.8% | 411.5% | -93.9% | -181.6% | 0.0% | |
| 33,004.2% | 320.8% | 1,917.5% | 554.9% | 1,584.1% | 1,281.9% | -4,198.5% | 1,625.1% | |
| 48,155.4% | 1,973.6% | -536.1% | -123.8% | -1,211.3% | 14,851.4% | -13,164.9% | -15,674.1% | |
| -44,562.2% | -1,132.8% | -2,344.8% | -1,257.4% | -2,715.1% | -2,343.6% | -2,905.2% | -9,183.5% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.